CLDX · Celldex Therapeutics, Inc. · Webcasts, Transcripts & Audio
$27.80
+0.25 (+0.91%)
At close · Nov 19
Return incl. dividend (before tax)
Q4 2021 earnings call transcript
Market Cap
$2.16B
Shares
78.55M
Volume · Nov 19
89.13K
Avg daily vol (3M)
1.33M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Celldex Therapeutics, Inc. Webcasts
Earnings calls, investor updates, investor days and conferences for Celldex Therapeutics, Inc. (CLDX), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Pull transcripts and briefs through the earnings call transcript API or MCP →
Add these events to your calendar (.ics)
Conference
Investor event
2026-12-01
Celldex Therapeutics, Inc. (CLDX) December 1, 2026 Conference
Scheduled
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-11-09
Celldex Therapeutics, Inc. (CLDX) November 9, 2026 Conference
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q2
2026-09-22
Celldex Therapeutics, Inc. (CLDX) Q2 2026 Earnings Call
Revenue
$22,000
▼ 97% YoY Diluted EPS
$-0.94
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-04-14
Celldex Therapeutics, Inc. (CLDX) April 14, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY25 · Q1
2025-05-08
Celldex Therapeutics, Inc. (CLDX) Q1 2025 Earnings Call
Revenue
$695,000
▲ 345.5% YoY Diluted EPS
$-0.81
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-02-28
Celldex Therapeutics, Inc. (CLDX) Q4 2021 Earnings Call Transcript
Revenue
$333,000*
▼ 91.2% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q2
2020-08-06
Celldex Therapeutics, Inc. (CLDX) Q2 2020 Earnings Call Transcript
Revenue
$236,000
▼ 67% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Showing 1–7 of 7 webcasts
Key facts
CIK
744218
CUSIP
15117B202
13F (30d)
267 filings
239 filers
Visit website
Investor relations